Redeye provides an in-depth review of AcouSort’s Q2 report and activities during and after the quarter. The report was largely undramatic, with financials broadly in line with our expectations. Following the report, we have made minor estimate adjustments, mainly reflecting the company’s continued cost control. We reiterate our fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/